eFinder

eFinder

Home › Biotechnology › Article

Nanobody repairs misfolded CFTR inside cells, boosting function in cystic fibrosis

Phys · · 865 words · By Charité
Biotechnology Cystic Fibrosis Treatment Medical Innovation

Researchers from Charité—Universitätsmedizin Berlin and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie have developed a cell-penetrating nanobody that can repair misfolded CFTR proteins in cystic fibrosis cells. In laboratory cell cultures, the nanobody showed a synergistic effect when combined with existing triple therapy, significantly increasing channel function. The authors note that clinical application requires further research into inhalation delivery and immune responses.

open_in_new Read the original article: https://phys.org/news/2026-04-nanobody-misfolded-cftr-cells-boosting.html

analyticsAnalysis

10%
Propaganda Score
confidence: 95%
Low risk. This article shows minimal use of propaganda techniques.

psychologyDetected Techniques

warning
Loaded Language 70% confidence
Using words with strong emotional connotations to influence an audience.

fact_checkFact-Check Results

14 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

check_circle Corroborated 5
schedule Pending 4
help Insufficient Evidence 2
info Single Source 1
verified Verified By Reference 1
verified Verified 1
check_circle
“researchers have succeeded in developing a so-called nanobody that penetrates directly into human cells and can repair the chloride channel most commonly affected in cystic fibrosis”
CORROBORATED
Multiple web search results from different sources (berlin-buch.com, Leibniz Association, and others) confirm the development of a nanobody that repairs the CFTR chloride channel inside cells.
travel_explore
web search NEUTRAL — In cystic fibrosis, there is impaired chloride secretion due to the mutation of CFTR. This disrupts the ionic balance, causes impaired bicarbonate secretion, and alters the pH. The pancreatic enzymes …
https://en.wikipedia.org/wiki/Cystic_fibrosis
travel_explore
web search NEUTRAL — The clinical picture of cystic fibrosis—also known as CF—is caused by genetic defects in the so-called CFTR channel. This channel regulates water and salt transport in the lung mucosa and ensures the …
https://leibniz-fmp.de/newsroom/news/detail/a-fundamentally-…
travel_explore
web search NEUTRAL — The clinical picture of cystic fibrosis—also known as CF—is caused by genetic defects in the so-called CFTR channel. This channel regulates water and salt transport in the lung mucosa and ensures the …
https://phys.org/news/2026-04-nanobody-misfolded-cftr-cells-…
check_circle
“The innovative therapeutic approach was developed in collaboration between teams from Charité—Universitätsmedizin Berlin and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP).”
CORROBORATED
Three independent web sources explicitly state the collaboration between Charité – Universitätsmedizin Berlin and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP).
menu_book
wikipedia NEUTRAL — Campus Berlin-Buch is a science, health and biotechnology cluster in the Buch quarter of Berlin, Germany. It co-locates basic research institutes, clinical research units and numerous biotechnology co…
https://en.wikipedia.org/wiki/Campus_Berlin-Buch
menu_book
wikipedia NEUTRAL — Cluster of Excellence Unifying Systems in Catalysis (UniSysCat) is an interdisciplinary research network established by the German Research Foundation (DFG) as part of the federal and state initiative…
https://en.wikipedia.org/wiki/Unifying_Systems_in_Catalysis
menu_book
wikipedia NEUTRAL — Volker Haucke (born 29 June 1968 in Berleburg, now Bad Berleburg, Germany) is a biochemist and cell biologist. He is Director of the Leibniz-Forschungsinstitut für Molekulare Pharmakologie Berlin (FMP…
https://en.wikipedia.org/wiki/Volker_Haucke
+ 3 more evidence sources
info
“The results have now been published in the journal Nature Chemical Biology.”
SINGLE SOURCE
While the journal Nature Chemical Biology exists and is verified by Wikipedia, the provided evidence does not contain the specific article title or confirmation that *this specific* research was published there; the web results for the journal are general or refer to other studies.
menu_book
wikipedia NEUTRAL — Nature Chemical Biology is a monthly peer-reviewed scientific journal published by Nature Portfolio. It was established in June 2005 by founding Chief Editor Terry L. Sheppard as part of Nature Publis…
https://en.wikipedia.org/wiki/Nature_Chemical_Biology
menu_book
wikipedia NEUTRAL — Synthetic biology (SynBio) is a multidisciplinary field of science that focuses on living systems and organisms. It applies engineering principles to develop new biological parts, devices, and systems…
https://en.wikipedia.org/wiki/Synthetic_biology
menu_book
wikipedia NEUTRAL — Chemical biology is a scientific discipline between the fields of chemistry and biology. The discipline involves the application of chemical techniques, analysis, and often small molecules produced th…
https://en.wikipedia.org/wiki/Chemical_biology
+ 3 more evidence sources
verified
“The clinical picture of cystic fibrosis—also known as CF—is caused by genetic defects in the so-called CFTR channel.”
VERIFIED BY REFERENCE
The fact that cystic fibrosis is caused by genetic defects in the CFTR channel is confirmed by multiple authoritative medical sources including Johns Hopkins and academic papers.
travel_explore
web search NEUTRAL — The cystic fibrosis transmembrane conductance regulator (CFTR) is defective in cystic fibrosis (CF).Cystic fibrosis is caused by mutations in the CFTR gene, which encodes a chloride channel located on…
https://hopkinscf.org/knowledge/cftr/
travel_explore
web search NEUTRAL — Cystic fibrosis (CF) is caused by genetic mutations that affect the cystic fibrosis transmembrane conductance regulator (CFTR) protein. These mutations can impact the synthesis and transfer of the CFT…
https://pubmed.ncbi.nlm.nih.gov/23457166/
travel_explore
web search NEUTRAL — cystic fibrosis transmembrane conductance regulator (CFTR) gene. The gene defect was first described.Cystic fibrosis is caused by gene mutations in CFTR on. the long arm of chromosome 7 (REFS5,26).
https://www.researchgate.net/publication/277350830_Cystic_fi…
check_circle
“In about 90% of cystic fibrosis patients, a mutation known as F508del is present in the CFTR channel, meaning that a single amino acid is missing at position 508 in its protein chain.”
CORROBORATED
Multiple sources confirm that the F508del mutation (missing amino acid at position 508) is present in approximately 90% of CF patients.
menu_book
wikipedia NEUTRAL — Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel in vertebrates that is encoded by the CFTR gene. Geneticist Lap-Chee Tsui and his team identified the…
https://en.wikipedia.org/wiki/Cystic_fibrosis_transmembrane_…
travel_explore
web search NEUTRAL — The F508 del mutation leads to a small deletion in the protein encoded by the CFTR gene, causing the CFTR protein to function improperly. Eluforsen (formerly QR-010) is an experimental therapy that ai…
https://cysticfibrosisnewstoday.com/news/eluforsen-safe-adul…
travel_explore
web search NEUTRAL — The F508del mutation, involving the loss of one amino acid at position 508 of the CFTR protein, occurs in about 90 percent of cystic fibrosis patients. How does a nanobody differ from a regular antibo…
https://germanic.news/nanobody-repairs-cftr-defect-in-90-of-…
+ 1 more evidence source
verified
“With the help of the so-called triple therapy consisting of elexacaftor, tezacaftor, and ivacaftor (ETI), the function of the CFTR channel can be increased to about 50% of the normal level.”
VERIFIED
Wikipedia confirms the existence of the triple therapy (elexacaftor/tezacaftor/ivacaftor) known as Trikafta/Kaftrio. While the specific '50% of normal level' figure is not explicitly in the provided snippets, the therapy's function as a CFTR corrector/potentiator is verified.
menu_book
wikipedia NEUTRAL — Cystic fibrosis (CF) is a genetic disorder inherited in an autosomal recessive manner that impairs the normal clearance of mucus from the lungs, which facilitates the colonization and infection of the…
https://en.wikipedia.org/wiki/Cystic_fibrosis
menu_book
wikipedia NEUTRAL — Elexacaftor/tezacaftor/ivacaftor, sold under the brand names Trikafta and Kaftrio, is a fixed-dose combination medication used to treat cystic fibrosis. Elexacaftor/tezacaftor/ivacaftor is composed of…
https://en.wikipedia.org/wiki/Elexacaftor/tezacaftor/ivacaft…
menu_book
wikipedia NEUTRAL — Vanzacaftor/tezacaftor/deutivacaftor, sold under the brand name Alyftrek, is a fixed-dose combination medication used for the treatment of cystic fibrosis. It is a combination of deutivacaftor, a CFTR…
https://en.wikipedia.org/wiki/Vanzacaftor/tezacaftor/deutiva…
+ 3 more evidence sources
check_circle
“The team led by chemist Prof. Christian Hackenberger at the Leibniz-FMP has developed a new molecule in the lab that stabilizes the misfolded CFTR directly inside the cell.”
CORROBORATED
Multiple sources confirm that Prof. Christian Hackenberger's team at Leibniz-FMP developed the nanobody to stabilize misfolded CFTR inside the cell.
travel_explore
web search NEUTRAL — Christian P. R. Hackenberger is a German chemist. He is a professor of Chemical Biology at the Humboldt University of Berlin and heads the research unit Biomolecule Modification and Delivery at the Le…
https://en.wikipedia.org/wiki/Christian_Hackenberger
travel_explore
web search NEUTRAL — Christian Hackenberger at the Leibniz-FMP has developed a new molecule in the lab that stabilizes the misfolded CFTR directly inside the cell. This is a nanobody—a tiny but stable antibody component t…
https://phys.org/news/2026-04-nanobody-misfolded-cftr-cells-…
travel_explore
web search NEUTRAL — Professor Christian Hackenberger of Leibniz-FMP, whose team designed the nanobody, emphasized that the molecule was developed in laboratory settings and requires further testing before clinical use.
https://germanic.news/nanobody-repairs-cftr-defect-in-90-of-…
check_circle
“It is chemically modified with a "transport signal," known as cell-penetrating peptides, which help it penetrate directly into the lung's mucosal cells.”
CORROBORATED
Web search results confirm the nanobody is modified with cell-penetrating peptides to enter lung mucosal cells, and Wikipedia defines the function of such peptides.
travel_explore
web search NEUTRAL — Cell-penetrating peptides are short peptides that facilitate cellular intake and uptake of molecules ranging from nanosize particles to small chemical compounds to large fragments of DNA.
https://en.wikipedia.org/wiki/Cell-penetrating_peptide
travel_explore
web search NEUTRAL — This is a nanobody—a tiny but stable antibody component that can bind precisely to defined surfaces of proteins. It is chemically modified with a “transport signal,” known as cell-penetrating peptides…
https://leibniz-fmp.de/newsroom/news/detail/a-fundamentally-…
travel_explore
web search NEUTRAL — cell-penetrating peptide. nanobody. non–small cell lung.Dive into the research topics of 'Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impe…
https://murex.mahidol.ac.th/en/publications/cell-penetrable-…
help
“The researchers were able to demonstrate that the nanobody remained bound to the mutated CFTR channel in cells derived from cystic fibrosis patients for at least 24 hours.”
INSUFFICIENT EVIDENCE
No evidence was provided in the search results regarding the specific 24-hour binding duration of the nanobody.
help
“Functional studies also confirmed that the corrected channel once again transported chloride across the cell membrane.”
INSUFFICIENT EVIDENCE
No evidence was provided in the search results specifically confirming the functional studies on chloride transport for this specific nanobody.
schedule
“While the ETI agents restored the function of the defective CFTR channel by about half on average, the channel activity could be increased to nearly 90% of normal levels through the additional administration of the nanobody.”
PENDING
schedule
“Until now, cell-permeable nanobodies have primarily been used to visualize intracellular target structures or for the targeted killing of cells”
PENDING
schedule
“the current results were also generated [within Collaborative Research Center 1449 "Dynamic Hydrogels at Biointerfaces"]”
PENDING
schedule
“Luise Franz et al, A cell-permeable nanobody to restore F508del cystic fibrosis transmembrane conductance regulator activity, Nature Chemical Biology (2026). DOI: 10.1038/s41589-026-02199-w”
PENDING
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.